At the time of writing, Immix Biopharma Inc [IMMX] stock is trading at $6.15, up 10.61%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IMMX shares have gain 52.61% over the last week, with a monthly amount glided 102.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
For the past year, the stock price of Immix Biopharma Inc fluctuated between $1.34 and $5.57. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Immix Biopharma Inc [NASDAQ: IMMX] shares were valued at $6.15 at the most recent close of the market. An investor can expect a potential return of 13.82% based on the average IMMX price forecast.
Analyzing the IMMX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.17, Equity is -2.64 and Total Capital is -2.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.05 points at the first support level, and at 3.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.70, and for the 2nd resistance point, it is at 7.25.
Ratios To Look Out For
It is important to note that Immix Biopharma Inc [NASDAQ:IMMX] has a current ratio of 1.53. Further, the Quick Ratio stands at 1.53, while the Cash Ratio is 1.47.
Transactions by insiders
Recent insider trading involved Rachman Ilya M, CEO and Chairman, that happened on Sep 17 ’25 when 2500.0 shares were purchased. CFO, Morris Gabriel S completed a deal on Sep 16 ’25 to buy 2600.0 shares. Meanwhile, CEO and Chairman Rachman Ilya M bought 2178.0 shares on Jun 18 ’25.
